Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Liabilities and Shareholders Equity (2020 - 2025)

Healthcare Triangle's Liabilities and Shareholders Equity history spans 6 years, with the latest figure at $13.8 million for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 190.35% year-over-year to $13.8 million; the TTM value through Sep 2025 reached $42.2 million, up 71.93%, while the annual FY2024 figure was $2.0 million, 71.41% down from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $13.8 million at Healthcare Triangle, down from $14.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $24.9 million in Q3 2022 and bottomed at $2.0 million in Q4 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $13.8 million (2025), against an average of $13.8 million.
  • The largest annual shift saw Liabilities and Shareholders Equity crashed 71.41% in 2024 before it skyrocketed 190.35% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $24.6 million in 2021, then crashed by 46.12% to $13.3 million in 2022, then plummeted by 48.29% to $6.9 million in 2023, then plummeted by 71.41% to $2.0 million in 2024, then surged by 605.66% to $13.8 million in 2025.
  • Per Business Quant, the three most recent readings for HCTI's Liabilities and Shareholders Equity are $13.8 million (Q3 2025), $14.6 million (Q2 2025), and $11.8 million (Q1 2025).